Commentary on "Conditional survival of patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A population-based study." Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK, Stanford Cancer Inst

Stephen Boorjian

doi:10.1016/j.urolonc.2012.11.006

Commentary on "Conditional survival of patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A population-based study." Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK, Stanford Cancer Inst

Stephen Boorjian

Urology

Research output: Contribution to journal › Short survey › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	127-128
Number of pages	2
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	31
Issue number	1
DOIs	https://doi.org/10.1016/j.urolonc.2012.11.006
State	Published - Jan 2013

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/j.urolonc.2012.11.006

Cite this

Boorjian, S. (2013). Commentary on "Conditional survival of patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A population-based study." Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK, Stanford Cancer Inst. Urologic Oncology: Seminars and Original Investigations, 31(1), 127-128. https://doi.org/10.1016/j.urolonc.2012.11.006

Commentary on "Conditional survival of patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A population-based study." Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK, Stanford Cancer Inst. / Boorjian, Stephen.
In: Urologic Oncology: Seminars and Original Investigations, Vol. 31, No. 1, 01.2013, p. 127-128.

Research output: Contribution to journal › Short survey › peer-review

Boorjian, S 2013, 'Commentary on "Conditional survival of patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A population-based study." Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK, Stanford Cancer Inst', Urologic Oncology: Seminars and Original Investigations, vol. 31, no. 1, pp. 127-128. https://doi.org/10.1016/j.urolonc.2012.11.006

Boorjian S. Commentary on "Conditional survival of patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A population-based study." Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK, Stanford Cancer Inst. Urologic Oncology: Seminars and Original Investigations. 2013 Jan;31(1):127-128. doi: 10.1016/j.urolonc.2012.11.006

Boorjian, Stephen. / Commentary on "Conditional survival of patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy : A population-based study." Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK, Stanford Cancer Inst. In: Urologic Oncology: Seminars and Original Investigations. 2013 ; Vol. 31, No. 1. pp. 127-128.

@article{8ee485a7be9145218369306782b02279,

title = "Commentary on {"}Conditional survival of patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A population-based study.{"} Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK, Stanford Cancer Inst",

author = "Stephen Boorjian",

year = "2013",

month = jan,

doi = "10.1016/j.urolonc.2012.11.006",

language = "English (US)",

volume = "31",

pages = "127--128",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Commentary on "Conditional survival of patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy

T2 - A population-based study." Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK, Stanford Cancer Inst

AU - Boorjian, Stephen

PY - 2013/1

Y1 - 2013/1

UR - http://www.scopus.com/inward/record.url?scp=84873908340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873908340&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2012.11.006

DO - 10.1016/j.urolonc.2012.11.006

M3 - Short survey

C2 - 23419724

AN - SCOPUS:84873908340

SN - 1078-1439

VL - 31

SP - 127

EP - 128

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 1

ER -

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this